ReWind Therapeutics (Public limited company)

BE 0682.626.216 Active ●Gaston Geenslaan 3, 3001 Louvain

ReWind Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0682.626.216. It was founded on 06-10-2017. Its registered office is in Leuven. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € -2 602 188 and a loss of € 4 636 777. These accounts report 4.9 full-time equivalents. Addrly gives it a financial health grade of C, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 14-10-2026.

Company information

Status
Active
Enterprise number
BE 0682.626.216
VAT registered
Yes
Founded
06-10-2017
Latest accounts
2025
Employees
4.9 FTE
Region
Flanders
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Gaston Geenslaan 3, 3001 Louvain
Main activity
Scientific research and development
NACE activities
72101 Recherche-développement en biotechnologie

Key figures of ReWind Therapeutics

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -4 636 777+2 %€ -4 747 033+16 %€ -5 655 155-25 %€ -4 511 572
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ -2 602 188+70 %€ -8 770 450-118 %€ -4 023 417€ 1 631 738
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 2 089 568-24 %€ 2 745 663-24 %€ 3 606 438-42 %€ 6 200 258
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -528 262-338 %€ -120 541+50 %€ -241 799+18 %€ -294 468
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
4.9-43 %8.6-10 %9.6+25 %7.7

Financial estimate

Financial health grade C, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
12 mandates on record in the annual accounts. 1 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Leuven.

CompanyTown
NELSON LABS 3001 Leuven
CUE - GRAPHICS 3001 Leuven
Antleron 3001 Leuven
RAMDESIGN 3001 Leuven
LIMITO 3001 Leuven
BETTER3FRUIT 3001 Leuven
HUAWEI TECHNOLOGIES RESEARCH & DEVELOPMENT BELGIUM 3001 Leuven
reMYND 3001 Leuven
Looking for more information about ReWind Therapeutics?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is ReWind Therapeutics still active? Yes. The Crossroads Bank for Enterprises lists ReWind Therapeutics as active.

What is the VAT number of ReWind Therapeutics? The VAT number of ReWind Therapeutics is BE 0682.626.216.

When was ReWind Therapeutics founded? ReWind Therapeutics was founded on 06-10-2017.

What is the address of ReWind Therapeutics? The current registered office of ReWind Therapeutics is Gaston Geenslaan 3, 3001 Louvain.

When did ReWind Therapeutics last file annual accounts? The latest annual accounts of ReWind Therapeutics were filed on 08-07-2026.

Does ReWind Therapeutics file its annual accounts on time? Yes. ReWind Therapeutics filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does ReWind Therapeutics have? ReWind Therapeutics employs 4.9 full-time equivalents according to its most recent annual accounts.

Is ReWind Therapeutics financially healthy? Addrly gives ReWind Therapeutics a financial health grade of C, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is ReWind Therapeutics profitable? The annual accounts of ReWind Therapeutics for 2025 show a loss of € 4 636 777.

What is the equity of ReWind Therapeutics? The equity of ReWind Therapeutics was € -2 602 188 at the close of the 2025 financial year.

Who are the directors of ReWind Therapeutics? The annual accounts of ReWind Therapeutics record 12 mandates. The names, roles and dates are visible with a free account.

Can ReWind Therapeutics receive Peppol e-invoices? Yes. ReWind Therapeutics is registered on the Peppol network and can receive structured electronic invoices.

What does ReWind Therapeutics do? The main activity of ReWind Therapeutics is: Scientific research and development.

Sources

How Addrly builds and refreshes this data